医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Blue Sail Shanghai Innovation Center (BSIC) Launched at ATLATL

2020年07月31日 AM12:45
このエントリーをはてなブックマークに追加


 

SHANGHAI

BLUE SAIL MEDICAL CO., LTD. (Blue Sail) opened its Blue Sail Shanghai Innovation Center (BSIC) in July 2020 at ATLATL Innovation Center, which built the customized GMP facility after a 10-month effort.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200730005761/en/

Blue Sail Shanghai Innovation Center (BSIC) at ATLATL (Photo: Business Wire)

Blue Sail Shanghai Innovation Center (BSIC) at ATLATL (Photo: Business Wire)

Blue Sail is the world’s largest vinyl glove enterprise (Shenzhen SE code: 002382). Blue Sail entered the cardiovascular arena after acquisition of Biosensors International Group, Ltd. (abbr. Biosensors), who has been developing and distributing critical care catheter systems and related devices used during heart surgery and intensive care. They have been working on drug-eluting stents, drug-coated stents, and bare metal stents, as well as angioplasty catheters for the treatment of coronary artery disease, offering interventional devices and solutions for patients living with coronary artery disease.

BSIC is located at the center of ZhangJiang High Tech Park, which is the hub of Medtech industry in China. “Leveraging the policy and talent resources in ZJ High Tech Park, BSIC will plays a key role in Bluesail’s global R&D system,” said Wenjing Liu, Chairman of Bluesail Medical. “BSIC will cooperate with R&D teams in Singapore and Germany to develop future products for coronary and structural heart segments, as well as starting the development of peripheral and neurovascular products from scratch.”

In the near future, Bluesail will have four product lines in the innovation center: Coronary intervention products, Structural heart products, Peripheral vascular products, and Neurovascular products.

With the concept of mutual building and sharing, Blue Sail built the platform for both health protection and health care via industry investment and venture capital. Blue Sail is committed to developing a world-class leading enterprise in the comprehensive medical industry as a famous brand trusted by the public.

“As the first medical device team in ATLATL, BSIC will affect our ecosystem,” said Dr. PC Zhu, the founder of ATLATL, which provides state-of-the-art facilities, advanced instruments, professional operations support, skilled laboratory personnel, on-site CROs, and the most creative module research services. “Partnering with BSIC, ATLATL will help commercialize more medical device companies, eventually benefitting the global healthcare industry.”

[“Atlatl” is a Nahuatl word that means “spear thrower”, which enabled ancient hunters to throw farther and faster, eventually generating greater returns. ATLATL is innovation’s spear thrower — to facilitate innovators’ growth and enhance their ability to reach milestones more quickly than ever.]

View source version on businesswire.com: https://www.businesswire.com/news/home/20200730005761/en/

CONTACT

ATLATL

Amanda Huo

info@atlatl.center

+86 21-58332229

同じカテゴリーの記事 

  • ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究
  • ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
  • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market
  • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
  • Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer